Park Ha Biological Technology Co, LTD F-1 registration statements

Park Ha Biological Technology Co., Ltd. filed an Amendment No. 3 to its Form F-1 Registration Statement, primarily to update exhibits and amend the exhibit index, with no changes to the prospectus content.

Park Ha Biological Technology Co., Ltd. announces a best-efforts public offering of 20 million units, each comprising one Class A Ordinary Share and one warrant, aiming to raise up to $2.8 million for store expansion.

Park Ha Biological Technology Co., Ltd. filed an F-1/A registration statement for a best-efforts public offering of up to 11,428,571 ordinary shares and accompanying warrants, aiming to raise approximately $3.5 million for store expansion.

Park Ha Biological Technology Co., Ltd. filed an F-1 registration statement for a follow-on offering of up to 11.4 million ordinary shares and warrants, while facing a Nasdaq minimum bid price deficiency notice.

Park Ha Biological Technology Co., Ltd. has filed an amendment to its registration statement for an initial public offering of 1,200,000 ordinary shares, with an expected price range of $4.00 to $6.00 per share.

Park Ha Biological Technology Co., Ltd. has filed Amendment No. 4 to its Form F-1 registration statement, primarily to include updated exhibits and an amended exhibit index.

Park Ha Biological Technology Co., Ltd. files an amendment to its Form F-1 registration statement for a proposed IPO and requests a waiver from the SEC regarding the age of its audited financial statements.

Park Ha Biological Technology Co., Ltd. plans to raise $6 million through an initial public offering of 1,200,000 ordinary shares, aiming for a Nasdaq listing.

Park Ha Biological Technology Co., Ltd. plans to offer 1,200,000 ordinary shares in an initial public offering, aiming for a Nasdaq listing.

Park Ha Biological Technology Co., Ltd. seeks to raise $7.2 million through an initial public offering of 1,200,000 ordinary shares, aiming for a Nasdaq listing under the symbol PHH.